[Thrombopoietin Promotes Megakaryopoiesis Protecting Bone Marrow Endothelial Function in Patients Undergoing Chemotherapy for Hematological Malignancies]

Overview

Journal Nan Fang Yi Ke Da Xue Xue Bao

Specialty General Medicine

Date 2020 Sep 8

PMID 32895184

Citations 1

Authors

Xiaoyuan Zeng

Yingying Jiao

Zongpeng Li

Yujiao Zhang

Jieyu Ye

Affiliations

Soon will be listed here.

Abstract

Objective: To explore whether thrombopoietin (TPO) can rescue megakaryopoiesis by protecting bone marrowderived endothelial progenitor cells (BM-EPCs) in patients receiving chemotherapy for hematological malignancies.

Methods: Bone marrow samples were collected from 23 patients with hematological malignancies 30 days after chemotherapy and from 10 healthy volunteers. BM-EPCs isolated from the samples were identified by staining for CD34, CD309 and CD133, and their proliferation in response to treatment with TPO was assessed using CCK8 assay. DiL-Ac-LDL uptake and FITC-UEA-I binding assay were performed to evaluate the amount of BM-EPCs from the subjects. Tube-formation and migration experiments were used for functional assessment of the BM-EPCs. The BM-EPCs with or without TPO treatment were co-cultured with human megakaryocytes, and the proliferation of the megakaryocytes was detected with flow cytometry.

Results: Flow cytometry indicated that the TPO-treated cells had high expressions of CD34, CD133, and CD309. CCK8 assay demonstrated that TPO treatment enhanced the proliferation of the BM-EPCs, and the optimal concentration of TPO was 100 μg/L. Double immunofluorescence assay indicated that the number of BM-EPC was significantly higher in TPO-treated group than in the control group. The TPO-treated BM-EPCs exhibited stronger tube-formation and migration abilities ( < 0.05) and more significantly enhanced the proliferation of co-cultured human megakaryocytes than the control cells ( < 0.05).

Conclusions: TPO can directly stimulate megakaryopoiesis and reduce hemorrhage via protecting the function of BM-EPCs in patients following chemotherapy for hematological malignancies.

Citing Articles

Experimental Study on the Effect of Allogeneic Endothelial Progenitor Cells on Wound Healing in Diabetic Mice.

Leng M, Peng Y, Pan M, Wang H J Diabetes Res. 2021; 2021:9962877.

PMID: 34722777 PMC: 8553455. DOI: 10.1155/2021/9962877.

References

Rafii S, Mohle R, Shapiro F, Frey B, Moore M . Regulation of hematopoiesis by microvascular endothelium. Leuk Lymphoma. 1998; 27(5-6):375-86. DOI: 10.3109/10428199709058305. View

Kuter D, Beeler D, Rosenberg R . The purification of megapoietin: a physiological regulator of megakaryocyte growth and platelet production. Proc Natl Acad Sci U S A. 1994; 91(23):11104-8. PMC: 45175. DOI: 10.1073/pnas.91.23.11104. View

Kuter D . The biology of thrombopoietin and thrombopoietin receptor agonists. Int J Hematol. 2013; 98(1):10-23. DOI: 10.1007/s12185-013-1382-0. View

Li Y, Huang Q, Wang C, Muhebaier , An L, Wang X . [Efficacy and safety of high-dose dexamethasone combined with rhTPO for newly diagnosed adults with severe immune thrombocytopenia]. Zhonghua Xue Ye Xue Za Zhi. 2016; 37(2):134-7. PMC: 7348189. View

Yan Z, Zeng L, Li Z, Zhang H, Chen W, Jia L . Bone marrow-derived endothelial progenitor cells promote hematopoietic reconstitution after hematopoietic stem cell transplantation. Transplant Proc. 2013; 45(1):427-33. DOI: 10.1016/j.transproceed.2012.03.064. View

Rafii S, Shapiro F, Pettengell R, Ferris B, Nachman R, Moore M . Human bone marrow microvascular endothelial cells support long-term proliferation and differentiation of myeloid and megakaryocytic progenitors. Blood. 1995; 86(9):3353-63. View

Zeng L, Chen C, Song G, Yan Z, Xu S, Jia L . Infusion of endothelial progenitor cells accelerates hematopoietic and immune reconstitution, and ameliorates the graft-versus-host disease after hematopoietic stem cell transplantation. Cell Biochem Biophys. 2012; 64(3):213-22. DOI: 10.1007/s12013-012-9387-5. View

Kiel M, Morrison S . Uncertainty in the niches that maintain haematopoietic stem cells. Nat Rev Immunol. 2008; 8(4):290-301. DOI: 10.1038/nri2279. View

Roumenina L, Rayes J, Frimat M, Fremeaux-Bacchi V . Endothelial cells: source, barrier, and target of defensive mediators. Immunol Rev. 2016; 274(1):307-329. DOI: 10.1111/imr.12479. View

10.

Kong Y, Chang Y, Wang Y, Chen Y, Han W, Wang Y . Association of an impaired bone marrow microenvironment with secondary poor graft function after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2013; 19(10):1465-73. DOI: 10.1016/j.bbmt.2013.07.014. View

11.

Salter A, Meadows S, Muramoto G, Himburg H, Doan P, Daher P . Endothelial progenitor cell infusion induces hematopoietic stem cell reconstitution in vivo. Blood. 2009; 113(9):2104-7. PMC: 2651019. DOI: 10.1182/blood-2008-06-162941. View

12.

Iwami Y, Masuda H, Asahara T . Endothelial progenitor cells: past, state of the art, and future. J Cell Mol Med. 2004; 8(4):488-97. PMC: 6740132. DOI: 10.1111/j.1582-4934.2004.tb00473.x. View

13.

Wang J, Ye J, Liang E, Yang M . [Thrombopoietin Prevents CoCl-inducing Apoptosis of HUVEC through the PI3K/AKT Pathway]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2018; 26(2):528-534. DOI: 10.7534/j.issn.1009-2137.2018.02.037. View

14.

Li B, Dai W . Thrombopoietin and neurotrophins share a common domain. Blood. 1995; 86(4):1643-4. View

15.

Kong Y, Shi M, Zhang Y, Cao X, Wang Y, Zhang X . N-acetyl-L-cysteine improves bone marrow endothelial progenitor cells in prolonged isolated thrombocytopenia patients post allogeneic hematopoietic stem cell transplantation. Am J Hematol. 2018; 93(7):931-942. DOI: 10.1002/ajh.25056. View

16.

Mitchell W, Bussel J . Thrombopoietin receptor agonists: a critical review. Semin Hematol. 2015; 52(1):46-52. DOI: 10.1053/j.seminhematol.2014.11.001. View

17.

Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T . Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997; 275(5302):964-7. DOI: 10.1126/science.275.5302.964. View

18.

Kanayasu-Toyoda T, Ishii-Watabe A, Suzuki T, Oshizawa T, Yamaguchi T . A new role of thrombopoietin enhancing ex vivo expansion of endothelial precursor cells derived from AC133-positive cells. J Biol Chem. 2007; 282(46):33507-33514. DOI: 10.1074/jbc.M703919200. View

19.

Xiao B, Ye J, Xu Y, Yang M . [Molecular mechanism of thrombopoietin signal pathways and its new effects]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013; 21(1):254-7. DOI: 10.7534/j.issn.1009-2137.2013.01.052. View

20.

Sheridan W, Kuter D . Mechanism of action and clinical trials of Mpl ligand. Curr Opin Hematol. 1997; 4(5):312-6. DOI: 10.1097/00062752-199704050-00003. View